Medibank PvtASX:MPL +2.67%77 Median PS Value is A$3.88 as of Jun. 25, 2026, which is 100% below its 10-year median of 1.30. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.38 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 343 Insurance companies, Medibank Pvt ranks worse than 67.93% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medibank Pvt's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.169. Medibank Pvt's 10-Year median PS Ratio is 1.2244. Therefore, the Median PS Value for today is A$3.88.
As of today (2026-06-25), Medibank Pvt's share price is A$4.99. Medibank Pvt's Median PS Value is A$3.88. Therefore, Medibank Pvt's Price to Median PS Value for today is 1.29.
The historical rank and industry rank for Medibank Pvt's Median PS Value or its related term are showing as below:
ASX:MPL'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.25 Med: 1.3 Max: 1.3
Current: 1.29
During the past 11 years, the highest Price to Median PS Value of Medibank Pvt was 1.30. The lowest was 1.25. And the median was 1.30.
ASX:MPL's Price-to-Median-PS-Value is ranked worse than 67.93% of 343
companies
in the Insurance industry
Industry Median: 0.99
vs ASX:MPL: 1.29
Medibank Pvt (ASX:MPL) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medibank Pvt's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
4.99
/
3.88
=
1.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt Median PS Value Related Terms
Medibank Pvt Median PS Value Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MPL vs FNF, AXS, FAF: Median PS Value Comparison
For the Insurance - Specialty subindustry, Medibank Pvt's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt Price-to-Median-PS-Value vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.2244.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medibank Pvt's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.169.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a Median PS Value of A$3.88 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medibank Pvt and its competitors. This is 198% above median its historical median of 1.30. Over the past decade, Medibank Pvt's Median PS Value has ranged from 1.25 to 1.30. According to the industry distribution chart, Medibank Pvt ranks #233 out of 343 companies in the Insurance industry, placing it in the top 67.9%.
Is Medibank Pvt's Median PS Value too high?
Medibank Pvt's current Median PS Value of A$3.88 is 198% above median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 1.25 to a high of 1.30. Based on the distribution chart, Medibank Pvt ranks #233 out of 343 companies in the Insurance industry, which is below the industry midpoint. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Median PS Value compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #233 out of 343 companies for Median PS Value. This places Medibank Pvt in the lower half of its industry. The industry median Median PS Value is 0.99. Historically, Medibank Pvt's own Median PS Value has ranged from 1.25 to 1.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for an Insurance company?
The median Median PS Value among Insurance companies is 0.99, based on 343 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medibank Pvt and its competitors. For the Insurance industry, the median Median PS Value is 0.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current Median PS Value is A$3.88, which is 198% above median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.38, compared to a current price of A$4.99 — trading 13.9% above its estimated fair value. The current Median PS Value is A$3.88, which is 198% above median its 10-year median of 1.30. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current Median PS Value is A$3.88 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$4.99 is trading 13.9% above its estimated GF Value™ of A$4.38.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
Median PS Value: A$3.88 (198% above median its 10-year median of 1.30)
GF Value™: A$4.38 vs. price of A$4.99 (13.9% above fair value)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score
Get the complete analysis for ASX:MPL
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
